Development, Vol 124, Issue 17 3375-3384, Copyright © 1997 by Company of Biologists

JOURNAL ARTICLES

Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2

S Iseki, AO Wilkie, JK Heath, T Ishimaru, K Eto and GM Morriss-Kay
Department of Human Anatomy, Oxford, UK.

Mutations in the human fibroblast growth factor receptor type 2 (FGFR2) gene cause craniosynostosis, particularly affecting the coronal suture. We show here that, in the fetal mouse skull vault, Fgfr2 transcripts are most abundant at the periphery of the membrane bones; they are mutually exclusive with those of osteopontin (an early marker of osteogenic differentiation) but coincide with sites of rapid cell proliferation. Fibroblast growth factor type 2 (FGF2) protein, which has a high affinity for the FGFR2 splice variant associated with craniosynostosis, is locally abundant; immunohistochemical detection showed it to be present at low levels in Fgfr2 expression domains and at high levels in differentiated areas. Implantation of FGF2-soaked beads onto the fetal coronal suture by ex utero surgery resulted in ectopic osteopontin expression, encircled by Fgfr2 expression, after 48 hours. We suggest that increased FGF/FGFR signalling in the developing skull, whether due to FGFR2 mutation or to ectopic FGF2, shifts the cell proliferation/differentiation balance towards differentiation by enhancing the normal paracrine down-regulation of Fgfr2.

This article has been cited by other articles:

				S. Li, N. Quarto, and M. T. Longaker Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1834 - C1842. [Abstract] [Full Text] [PDF]

				M. Tanaka, S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid J. Biol. Chem., September 1, 2006; 281(35): 25822 - 25830. [Abstract] [Full Text] [PDF]

				R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling Development, January 1, 2006; 133(1): 63 - 74. [Abstract] [Full Text] [PDF]

				Y. Tanimoto, M. Yokozeki, K. Hiura, K. Matsumoto, H. Nakanishi, T. Matsumoto, P. J. Marie, and K. Moriyama A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome J. Biol. Chem., October 29, 2004; 279(44): 45926 - 45934. [Abstract] [Full Text] [PDF]

				M. K. Hajihosseini, M. D. Lalioti, S. Arthaud, H. R. Burgar, J. M. Brown, S. R. F. Twigg, A. O. M. Wilkie, and J. K. Heath Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics Development, January 15, 2004; 131(2): 325 - 335. [Abstract] [Full Text] [PDF]

				C. M. Cowan, N. Quarto, S. M. Warren, A. Salim, and M. T. Longaker Age-related Changes in the Biomolecular Mechanisms of Clvarial Osteoblast Biology Affect Fibroblast Growth Factor-2 Signaling and Osteogenesis J. Biol. Chem., August 22, 2003; 278(34): 32005 - 32013. [Abstract] [Full Text] [PDF]

				V. P. Eswarakumar, E. Monsonego-Ornan, M. Pines, I. Antonopoulou, G. M. Morriss-Kay, and P. Lonai The IIIc alternative of Fgfr2 is a positive regulator of bone formation Development, March 10, 2003; 129(16): 3783 - 3793. [Abstract] [Full Text] [PDF]

				D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF]

				N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi, T. Fujimori, N. Itoh, and S. Takada FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis Genes & Dev., April 1, 2002; 16(7): 870 - 879. [Abstract] [Full Text] [PDF]

				M. K. Hajihosseini, S. Wilson, L. De Moerlooze, and C. Dickson A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes PNAS, March 27, 2001; 98(7): 3855 - 3860. [Abstract] [Full Text] [PDF]

				K. Yu, A. B. Herr, G. Waksman, and D. M. Ornitz Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome PNAS, December 19, 2000; 97(26): 14536 - 14541. [Abstract] [Full Text] [PDF]

				Y.-X. Zhou, X. Xu, L. Chen, C. Li, S. G. Brodie, and C.-X. Deng A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures Hum. Mol. Genet., August 12, 2000; 9(13): 2001 - 2008. [Abstract] [Full Text] [PDF]

				A. Mansukhani, P. Bellosta, M. Sahni, and C. Basilico Signaling by Fibroblast Growth Factors (FGF) and Fibroblast Growth Factor Receptor 2 (FGFR2)-activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts J. Cell Biol., June 12, 2000; 149(6): 1297 - 1308. [Abstract] [Full Text] [PDF]

				H. Makarenkova, M Ito, V Govindarajan, S. Faber, L Sun, G McMahon, P. Overbeek, and R. Lang FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development Development, January 6, 2000; 127(12): 2563 - 2572. [Abstract] [PDF]

				D. Rice, T Aberg, Y Chan, Z Tang, P. Kettunen, L Pakarinen, R. Maxson, and I Thesleff Integration of FGF and TWIST in calvarial bone and suture development Development, January 5, 2000; 127(9): 1845 - 1855. [Abstract] [PDF]

				S Iseki, A. Wilkie, and G. Morriss-Kay Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault Development, January 12, 1999; 126(24): 5611 - 5620. [Abstract] [PDF]

				H. Kim, D. Rice, P. Kettunen, and I Thesleff FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development Development, January 4, 1998; 125(7): 1241 - 1251. [Abstract] [PDF]